Skip to content

TPG and Blackstone Pursue Joint Bid for Bausch + Lomb

๐“๐๐† ๐š๐ง๐ ๐๐ฅ๐š๐œ๐ค๐ฌ๐ญ๐จ๐ง๐ž ๐๐ฎ๐ซ๐ฌ๐ฎ๐ž ๐‰๐จ๐ข๐ง๐ญ ๐๐ข๐ ๐Ÿ๐จ๐ซ ๐๐š๐ฎ๐ฌ๐œ๐ก + ๐‹๐จ๐ฆ๐›

๐Ÿค Private equity firms TPG and Blackstone are teaming up to make a joint bid for Bausch + Lomb, a major player in the eyecare industry. As of last Friday, Bausch + Lomb has an enterprise value, including debt, of approximately $11.5 billion. If successful, this deal could rank among the largest private equity buyouts of the year.

๐Ÿ‘€ This move comes amid tensions between shareholders and creditors of Bausch Health, the parent company that owns 88 percent of Bausch + Lomb. The acquisition aims to resolve these disputes and stabilize the company.

๐Ÿ‘ With growing demand for innovative eyecare solutions, this collaboration highlights the increasing interest from private equity in the healthcare sector, particularly within niche markets like eyecare. Stakeholders will be closely watching how this bid develops in the coming weeks.